These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6775006)

  • 21. Incidence and characterization of beta-hemolytic Streptococcus milleri and differentiation from S. pyogenes (group A), S. equisimilis (group C), and large-colony group G streptococci.
    Lawrence J; Yajko DM; Hadley WK
    J Clin Microbiol; 1985 Nov; 22(5):772-7. PubMed ID: 3902878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Streptococcus sinensis may react with Lancefield group F antiserum.
    Woo PC; Teng JL; Leung KW; Lau SK; Tse H; Wong BH; Yuen KY
    J Med Microbiol; 2004 Nov; 53(Pt 11):1083-1088. PubMed ID: 15496384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of diacetyl (caramel odor) in presumptive identification of the "Streptococcus milleri" group.
    Chew TA; Smith JM
    J Clin Microbiol; 1992 Nov; 30(11):3028-9. PubMed ID: 1452678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physiological differentiation of viridans streptococci.
    Facklam RR
    J Clin Microbiol; 1977 Feb; 5(2):184-201. PubMed ID: 845245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. groESL sequence determination, phylogenetic analysis, and species differentiation for viridans group streptococci.
    Teng LJ; Hsueh PR; Tsai JC; Chen PW; Hsu JC; Lai HC; Lee CN; Ho SW
    J Clin Microbiol; 2002 Sep; 40(9):3172-8. PubMed ID: 12202549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of clinically relevant viridans streptococci by analysis of transfer DNA intergenic spacer length polymorphism.
    De Gheldre Y; Vandamme P; Goossens H; Struelens MJ
    Int J Syst Bacteriol; 1999 Oct; 49 Pt 4():1591-8. PubMed ID: 10555340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presumptive speciation of Streptococcus bovis and other group D streptococci from human sources by using arginine and pyruvate tests.
    Gross KC; Houghton MP; Senterfit LB
    J Clin Microbiol; 1975 Jan; 1(1):54-60. PubMed ID: 1176592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A note on a code for the identification of the 'viridans' streptococci.
    Coogan MM
    J Appl Bacteriol; 1985 May; 58(5):513-5. PubMed ID: 4008373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of phylogenetic and phenotypic analyses to identify nonhemolytic streptococci isolated from bacteremic patients.
    Hoshino T; Fujiwara T; Kilian M
    J Clin Microbiol; 2005 Dec; 43(12):6073-85. PubMed ID: 16333101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiological characterization of nutritionally variant streptococci.
    Cooksey RC; Thompson FS; Facklam RR
    J Clin Microbiol; 1979 Sep; 10(3):326-30. PubMed ID: 489722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular pathogenicity of Streptococcus anginosus.
    Asam D; Spellerberg B
    Mol Oral Microbiol; 2014 Aug; 29(4):145-55. PubMed ID: 24848553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions between Eikenella corrodens and 'Streptococcus milleri-group' organisms: possible mechanisms of pathogenicity in mixed infections.
    Young KA; Allaker RP; Hardie JM; Whiley RA
    Antonie Van Leeuwenhoek; 1996 May; 69(4):371-3. PubMed ID: 8836435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of three methods for identification of Streptococcus milleri group isolates to species level.
    Limia A; Alarcón T; Jiménez ML; López-Brea M
    Eur J Clin Microbiol Infect Dis; 2000 Feb; 19(2):128-31. PubMed ID: 10746501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Viridans streptococci in human infections: identification and susceptibility to antibiotics].
    Horodniceanu T; Delbos F
    Ann Microbiol (Paris); 1982; 133(2):255-69. PubMed ID: 7149526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of Streptococcus bovis and Streptococcus salivarius in clinical laboratories.
    Ruoff KL; Ferraro MJ; Holden J; Kunz LJ
    J Clin Microbiol; 1984 Aug; 20(2):223-6. PubMed ID: 6490816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell surface hydrophobicity of group D and viridans streptococci isolated from patients with septicaemia.
    Ljungh A; Osterlind M; Wadström T
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 May; 261(3):280-6. PubMed ID: 3090804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Classification and identification of the viridans streptococci.
    Coykendall AL
    Clin Microbiol Rev; 1989 Jul; 2(3):315-28. PubMed ID: 2670193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viridans streptococci isolated from the bloodstream. Relevance of species identification.
    Jacobs JA; Schouten HC; Stobberingh EE; Soeters PB
    Diagn Microbiol Infect Dis; 1995 Jul; 22(3):267-73. PubMed ID: 8565415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emended descriptions and recognition of Streptococcus constellatus, Streptococcus intermedius, and Streptococcus anginosus as distinct species.
    Whiley RA; Beighton D
    Int J Syst Bacteriol; 1991 Jan; 41(1):1-5. PubMed ID: 1995029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utilization of sialic acid by viridans streptococci.
    Byers HL; Homer KA; Beighton D
    J Dent Res; 1996 Aug; 75(8):1564-71. PubMed ID: 8906124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.